An evaluation of asciminib for patients with chronic myeloid leukemia previously treated with ≥2 tyrosine kinase inhibitors

  1. García-Gutiérrez, V.
  2. Hernandez-Boluda, J.C.
Revue:
Expert Review of Hematology

ISSN: 1747-4094,  1747-4086

Année de publication: 2022

Volumen: 15

Número: 6

Pages: 477-484

Type: Article

DOI: 10.1080/17474086.2022.2080049 GOOGLE SCHOLAR
La source de données: Scopus